Douglas S. Ingram, Director at Relay Therapeutics, Inc. (RLAY), bought 25,000 shares at $20.00 ($500K) on 2020-07-20, disclosed to the SEC on 2020-07-21.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| SRPT | BUY | 2019-08-12 | $4.0M | — | Filing → |
| SRPT | BUY | 2018-10-30 | $4.0M | — | Filing → |
| SRPT | BUY | 2018-08-16 | $2.0M | — | Filing → |